| Name | Bio Concepts Inc |
|---|---|
| Organization Name | Bio-concepts, Inc. |
| Location | 2424 E University Drive, Phoenix, Arizona 85034 |
| Type | DME Supplier - Customized Equipment |
| Phone | (800) 421-5647 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
A selection of health policy stories from Minnesota, Maryland, Colorado, New York, California, Washington state, Michigan and Massachusetts.
Springer has launched a network of job sites designed to attract and showcase the unique talent and highly qualified audience that uses Springer tools which are some of the industry's most trusted, prestigious and trafficked sites for research.
Universal Capital Management, Inc. announced today a non-binding letter of intent to purchase ProShield assets, a product owned by Seitz Technical Products, Inc.
› Verified 3 days ago
| NPI Number | 1437229671 |
| Organization Name | BIO-CONCEPTS, INC. |
| Type | DME Supplier - Customized Equipment |
| Address | 2424 E University Dr, Phoenix, AZ 85034 |
| Phone Number | 602-267-7854 |
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
A selection of health policy stories from Minnesota, Maryland, Colorado, New York, California, Washington state, Michigan and Massachusetts.
Springer has launched a network of job sites designed to attract and showcase the unique talent and highly qualified audience that uses Springer tools which are some of the industry's most trusted, prestigious and trafficked sites for research.
Universal Capital Management, Inc. announced today a non-binding letter of intent to purchase ProShield assets, a product owned by Seitz Technical Products, Inc.
› Verified 3 days ago
News Archive
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals and leading education initiatives, discussions, and policy actions central to improving the development and application of molecular diagnostics, today reaffirmed its position that the vast majority of laboratory developed tests (LDTs), or laboratory developed procedures (LDPs)—a term coined by AMP to more appropriately capture the nature of these processes as medical services—should continue operating under the regulation of the Clinical Laboratory Improvement Amendments program at the Centers for Medicare & Medicaid Services, and not be subject to pre-market review by the U.S. Food and Drug Administration, as suggested in the draft guidance notification issued to Congress on July 31, 2014.
A selection of health policy stories from Minnesota, Maryland, Colorado, New York, California, Washington state, Michigan and Massachusetts.
Springer has launched a network of job sites designed to attract and showcase the unique talent and highly qualified audience that uses Springer tools which are some of the industry's most trusted, prestigious and trafficked sites for research.
Universal Capital Management, Inc. announced today a non-binding letter of intent to purchase ProShield assets, a product owned by Seitz Technical Products, Inc.
› Verified 3 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |